Search research articles
Contact Us
Filters
Showing results (321-330 of 353) with videos related to
Page
of 36
Sort By:
Blood
|
May 28, 2017
A phase 1/2 study of the oral proteasome inhibitor ixazomib in relapsed or refractory AL amyloidosis
Vaishali Sanchorawala, Giovanni Palladini, Vishal Kukreti, et al.
Journal of Hematology & Oncology
|
September 5, 2015
Pharmacokinetics and safety of ixazomib plus lenalidomide-dexamethasone in Asian patients with relapsed/refractory myeloma: a phase 1 study
Neeraj Gupta, Yeow Tee Goh, Chang-Ki Min, et al.
The Indian Journal of Tuberculosis
|
November 9, 2021
Thoracoscopic practices in India-a survey by Indian chest society
Rakesh K Chawla, D J Christopher, Raja Dhar, et al.
Indian Journal of Critical Care Medicine : Peer-Reviewed, Official Publication of Indian Society of Critical Care Medicine
|
December 17, 2021
COVID-19-associated Multisystem Inflammatory Syndrome in Children: A Multicentric Retrospective Cohort Study
Bharat Mehra, Mukul Pandey, Dhiren Gupta, et al.
Journal of Clinical Pharmacology
|
August 12, 2017
Effects of Strong CYP3A Inhibition and Induction on the Pharmacokinetics of Ixazomib, an Oral Proteasome Inhibitor: Results of Drug-Drug Interaction Studies in Patients With Advanced Solid Tumors or Lymphoma and a Physiologically Based Pharmacokinetic Analysis
Neeraj Gupta, Michael J Hanley, Karthik Venkatakrishnan, et al.
Indian Pediatrics
|
August 28, 2024
Comparative Efficacy of Interventions for Analgesia During Heel Prick in Newborn Infants - A Systematic Review and Network Meta-Analysis
Thangaraj Abiramalatha, Viraraghavan Vadakkencherry Ramaswamy, Rajendra Prasad Anne, et al.
Haematologica
|
June 30, 2018
A phase I/II dose-escalation study investigating all-oral ixazomib-melphalan-prednisone induction followed by single-agent ixazomib maintenance in transplant-ineligible newly diagnosed multiple myeloma
Jesús F San-Miguel, Maria-Asunción Echeveste Gutierrez, Ivan Špicka, et al.
American Journal of Industrial Medicine
|
November 19, 2009
Occupational health crossing borders part 2: Comparison of 18 occupational health systems across the globe
Katja Radon, Vera Ehrenstein, Dennis Nowak, et al.
Lung India : Official Organ of Indian Chest Society
|
January 6, 2021
Survival predictors of interstitial lung disease in India: Follow-up of Interstitial Lung Disease India registry
Sheetu Singh, Mohan Bairwa, Bridget F Collins, et al.
British Journal of Haematology
|
June 26, 2018
Twice-weekly ixazomib in combination with lenalidomide-dexamethasone in patients with newly diagnosed multiple myeloma
Paul G Richardson, Craig C Hofmeister, Cara A Rosenbaum, et al.
Page
of 36
Search research articles
Search
Showing results (321-330 of 353) with videos related to
Sort By:
Page
of 36
Blood
|
May 28, 2017
A phase 1/2 study of the oral proteasome inhibitor ixazomib in relapsed or refractory AL amyloidosis
Vaishali Sanchorawala, Giovanni Palladini, Vishal Kukreti, et al.
Journal of Hematology & Oncology
|
September 5, 2015
Pharmacokinetics and safety of ixazomib plus lenalidomide-dexamethasone in Asian patients with relapsed/refractory myeloma: a phase 1 study
Neeraj Gupta, Yeow Tee Goh, Chang-Ki Min, et al.
The Indian Journal of Tuberculosis
|
November 9, 2021
Thoracoscopic practices in India-a survey by Indian chest society
Rakesh K Chawla, D J Christopher, Raja Dhar, et al.
Indian Journal of Critical Care Medicine : Peer-Reviewed, Official Publication of Indian Society of Critical Care Medicine
|
December 17, 2021
COVID-19-associated Multisystem Inflammatory Syndrome in Children: A Multicentric Retrospective Cohort Study
Bharat Mehra, Mukul Pandey, Dhiren Gupta, et al.
Journal of Clinical Pharmacology
|
August 12, 2017
Effects of Strong CYP3A Inhibition and Induction on the Pharmacokinetics of Ixazomib, an Oral Proteasome Inhibitor: Results of Drug-Drug Interaction Studies in Patients With Advanced Solid Tumors or Lymphoma and a Physiologically Based Pharmacokinetic Analysis
Neeraj Gupta, Michael J Hanley, Karthik Venkatakrishnan, et al.
Indian Pediatrics
|
August 28, 2024
Comparative Efficacy of Interventions for Analgesia During Heel Prick in Newborn Infants - A Systematic Review and Network Meta-Analysis
Thangaraj Abiramalatha, Viraraghavan Vadakkencherry Ramaswamy, Rajendra Prasad Anne, et al.
Haematologica
|
June 30, 2018
A phase I/II dose-escalation study investigating all-oral ixazomib-melphalan-prednisone induction followed by single-agent ixazomib maintenance in transplant-ineligible newly diagnosed multiple myeloma
Jesús F San-Miguel, Maria-Asunción Echeveste Gutierrez, Ivan Špicka, et al.
American Journal of Industrial Medicine
|
November 19, 2009
Occupational health crossing borders part 2: Comparison of 18 occupational health systems across the globe
Katja Radon, Vera Ehrenstein, Dennis Nowak, et al.
Lung India : Official Organ of Indian Chest Society
|
January 6, 2021
Survival predictors of interstitial lung disease in India: Follow-up of Interstitial Lung Disease India registry
Sheetu Singh, Mohan Bairwa, Bridget F Collins, et al.
British Journal of Haematology
|
June 26, 2018
Twice-weekly ixazomib in combination with lenalidomide-dexamethasone in patients with newly diagnosed multiple myeloma
Paul G Richardson, Craig C Hofmeister, Cara A Rosenbaum, et al.
Page
of 36